Conditions: Hepatitis C Infection Hepatitis C Virus
Keywords: Hepatitis C Virus Interferon-Free Ribavirin-Free Hepatitis C Hepatitis C Genotype 1b
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 166
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of ombitasvir/paritaprevir/ ritonavir and dasabuvir administered for 8 weeks in treatment-naïve participants with genotype 1b (GT1b) hepatitis C virus (HCV).

Detailed description:

Arms:
arm 1: Ombitasvir/Paritaprevir/Ritonavir(25 mg/150 mg/100 mg once daily) and Dasabuvir (250 mg twice daily) administered for 8 weeks

Interventions: intervention 1: ombitasvir/paritaprevir/ritonavir intervention 2: dasabuvir
Intervention descriptions: intervention 1: Tablet intervention 2: Tablet

Protocol document: